We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can Oscar Health Turn ACA Marketplace Growth Into Lasting Profits?
Read MoreHide Full Article
Key Takeaways
OSCR's ACA marketplace growth offers opportunities, but sustainable profits hinge on cost discipline.
OSCR plans to enter over 150 additional metro areas by 2027, expanding its geographic reach & customer base.
OSCR shares have surged 130% year to date, but its 4.94 price-to-book ratio exceeds the industry's 2.64.
Oscar Health’s (OSCR - Free Report) growth prospects remain closely linked to the expansion of the Affordable Care Act (ACA) marketplace. However, the key question is whether its recent momentum reflects a lasting competitive advantage or continued reliance on favorable policy and market conditions.
Enhanced premium subsidies have historically improved affordability and supported marketplace enrollment, enabling Oscar to attract members through its technology-driven platform, consumer-focused offerings and expanding provider relationships. A growing membership base could strengthen operating leverage by spreading technology and administrative expenses across more customers. Disciplined pricing and improved medical-cost management could further help convert enrollment gains into sustainable profitability.
Oscar’s expansion plans also offer meaningful growth opportunities. The company aims to enter more than 150 additional metropolitan statistical areas by 2027, broadening its geographic footprint and customer reach. Its strategy aligns with healthcare trends such as digitalization, rising demand for personalized services and increasing emphasis on affordable coverage.
Nevertheless, Oscar’s significant ACA exposure presents a concentration risk. Changes in subsidy policies could weaken affordability, increase member churn and alter the membership risk profile, potentially putting pressure on underwriting margins. Rising medical utilization and pricing missteps could further undermine profitability.
Ultimately, Oscar’s long-term growth sustainability will depend on its ability to translate membership expansion into consistent earnings through disciplined underwriting, cost efficiency and technological advantages, rather than relying primarily on supportive policies and favorable industry conditions.
What About Peers?
Molina Healthcare (MOH - Free Report) is well positioned to benefit from several long-term trends supporting government-sponsored healthcare. As of June 30, 2026, total membership of Molina Healthcare decreased 14.3% year over year to around 4.9 million. Rising healthcare utilization, an aging U.S. population and a strategic shift toward D-SNPs should support sustained membership growth for Molina Healthcare.
Centene Corporation (CNC - Free Report) has shifted its strategy from prioritizing membership growth to improving earnings quality through disciplined pricing and portfolio optimization. Centene continues to benefit from a large and diversified membership base supported by contract wins and expansion in attractive government-sponsored programs. Centene is also shifting toward higher-quality membership, including growing PDP and dual-eligible Medicare exposure.
OSCR’s Price Performance
Shares of Oscar Health have gained 130.3% year to date, outperforming the industry.
Image Source: Zacks Investment Research
OSCR’s Expensive Valuation
The stock is overvalued compared with its industry. It is currently trading at a price-to-book multiple of 4.94, higher than the industry average of 2.64.
Image Source: Zacks Investment Research
Estimate Movement for OSCR
The Zacks Consensus Estimate for OSCR’s third-quarter and fourth-quarter 2026 bottom line witnessed positive movement in the last 30 days. The same holds true for 2026 and 2027.
Image Source: Zacks Investment Research
The consensus estimates for OSCR’s 2026 and 2027 revenues and earnings indicate year-over-year decreases.
View the Zacks #1 Rank List
Image: Bigstock
Can Oscar Health Turn ACA Marketplace Growth Into Lasting Profits?
Key Takeaways
Oscar Health’s (OSCR - Free Report) growth prospects remain closely linked to the expansion of the Affordable Care Act (ACA) marketplace. However, the key question is whether its recent momentum reflects a lasting competitive advantage or continued reliance on favorable policy and market conditions.
Enhanced premium subsidies have historically improved affordability and supported marketplace enrollment, enabling Oscar to attract members through its technology-driven platform, consumer-focused offerings and expanding provider relationships. A growing membership base could strengthen operating leverage by spreading technology and administrative expenses across more customers. Disciplined pricing and improved medical-cost management could further help convert enrollment gains into sustainable profitability.
Oscar’s expansion plans also offer meaningful growth opportunities. The company aims to enter more than 150 additional metropolitan statistical areas by 2027, broadening its geographic footprint and customer reach. Its strategy aligns with healthcare trends such as digitalization, rising demand for personalized services and increasing emphasis on affordable coverage.
Nevertheless, Oscar’s significant ACA exposure presents a concentration risk. Changes in subsidy policies could weaken affordability, increase member churn and alter the membership risk profile, potentially putting pressure on underwriting margins. Rising medical utilization and pricing missteps could further undermine profitability.
Ultimately, Oscar’s long-term growth sustainability will depend on its ability to translate membership expansion into consistent earnings through disciplined underwriting, cost efficiency and technological advantages, rather than relying primarily on supportive policies and favorable industry conditions.
What About Peers?
Molina Healthcare (MOH - Free Report) is well positioned to benefit from several long-term trends supporting government-sponsored healthcare. As of June 30, 2026, total membership of Molina Healthcare decreased 14.3% year over year to around 4.9 million. Rising healthcare utilization, an aging U.S. population and a strategic shift toward D-SNPs should support sustained membership growth for Molina Healthcare.
Centene Corporation (CNC - Free Report) has shifted its strategy from prioritizing membership growth to improving earnings quality through disciplined pricing and portfolio optimization. Centene continues to benefit from a large and diversified membership base supported by contract wins and expansion in attractive government-sponsored programs. Centene is also shifting toward higher-quality membership, including growing PDP and dual-eligible Medicare exposure.
OSCR’s Price Performance
Shares of Oscar Health have gained 130.3% year to date, outperforming the industry.
Image Source: Zacks Investment Research
OSCR’s Expensive Valuation
The stock is overvalued compared with its industry. It is currently trading at a price-to-book multiple of 4.94, higher than the industry average of 2.64.
Image Source: Zacks Investment Research
Estimate Movement for OSCR
The Zacks Consensus Estimate for OSCR’s third-quarter and fourth-quarter 2026 bottom line witnessed positive movement in the last 30 days. The same holds true for 2026 and 2027.
Image Source: Zacks Investment Research
The consensus estimates for OSCR’s 2026 and 2027 revenues and earnings indicate year-over-year decreases.
OSCR stock currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.